← Back to Search

Procedure

High power ablation for Heart Disease

N/A
Waitlist Available
Led By Sergey V. Korolev, MD
Research Sponsored by Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to one year
Awards & highlights

Study Summary

This study is evaluating whether high power radiofrequency ablation is safe and more effective than standard power radiofrequency ablation.

Eligible Conditions
  • Heart Disease
  • Ventricular Tachycardia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The inducibility of the clinical VT at the end of ablation procedure
The number of episodes of ICD therapy
The number of intraoperative complications
+1 more
Secondary outcome measures
All-cause mortality
Freedom from recurrent VT
The number of antiarrhythmic drugs
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High power ablationExperimental Treatment1 Intervention
High power ablation parameters (50-55 W)
Group II: Standard ablation powerActive Control1 Intervention
Standard ablation power parameters (40-45 W)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High power ablation
2020
N/A
~120

Find a Location

Who is running the clinical trial?

Heart and Vascular Center Bad Bevensen, GermanyUNKNOWN
National Medical Research Center for Cardiology, Ministry of Health of Russian FederationOTHER_GOV
17 Previous Clinical Trials
50,002 Total Patients Enrolled
National Research Center of Surgery, RussiaOTHER_GOV
4 Previous Clinical Trials
740 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~27 spots leftby Apr 2025